Evidence-based child health : a Cochrane review journal
-
Evid Based Child Health · Jul 2013
ReviewProphylactic drug management for febrile seizures in children (Review).
Febrile seizures occurring in a child older than one month during an episode of fever affect 2% to 4% of children in Great Britain and the United States and recur in 30%. Rapid-acting antiepileptics and antipyretics given during subsequent fever episodes have been used to avoid the adverse effects of continuous antiepileptic drugs. ⋯ No clinically important benefits for children with febrile seizures were found for intermittent oral diazepam, phenytoin, phenobarbitone, intermittent rectal diazepam, valproate, pyridoxine, intermittent phenobarbitone or intermittent ibuprofen, nor for diclofenac versus placebo followed by ibuprofen, acetominophen or placebo. Adverse effects were reported in up to 30% of children. Apparent benefit for clobazam treatment in one recent trial needs to be replicated to be judged reliable. Given the benign nature of recurrent febrile seizures, and the high prevalence of adverse effects of these drugs, parents and families should be supported with adequate contact details of medical services and information on recurrence, first aid management and, most importantly, the benign nature of the phenomenon.
-
Evid Based Child Health · Jul 2013
CommentCommentary on ‘propofol versus thiopental sodium for the treatment of refractory status epilepticus—still no answer’.
This is a commentary on a Cochrane review, published in this issue of EBCH, first published as:Prabhakar H, Bindra A, Singh GP, Kalaivani M. Propofol versus thiopental sodium for the treatment ofrefractory status epilepticus. Cochrane Database of Systematic Reviews 2012, Issue 8. ⋯ No.: CD009202. DOI: 10.1002/14651858. CD009202.pub2.
-
Evid Based Child Health · Jul 2013
CommentCommentaries on 'procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections' with a response from the review authors.
These are commentaries on a Cochrane review, published in this issue of EBCH, first published as: Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bhatnagar N, Bucher HC, Briel M. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database of Systematic Reviews 2012, Issue 9. ⋯ No.: CD007498. DOI: 10.1002/14651858. CD007498.pub2.